These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17534819)

  • 1. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration.
    Sakamoto H; Sakamoto M; Hata Y; Kubota T; Ishibashi T
    Eur J Ophthalmol; 2007; 17(3):372-6. PubMed ID: 17534819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
    Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
    Retina; 1998; 18(6):521-5. PubMed ID: 9869460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous.
    Yalvac IS; Basci NE; Bozkurt A; Duman S
    J Cataract Refract Surg; 2003 Mar; 29(3):487-91. PubMed ID: 12663011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin.
    Donnenfeld ED; Perry HD; Snyder RW; Moadel R; Elsky M; Jones H
    Arch Ophthalmol; 1997 Feb; 115(2):173-6. PubMed ID: 9046250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous and vitreous penetration of levofloxacin after oral administration.
    Fiscella RG; Nguyen TK; Cwik MJ; Phillpotts BA; Friedlander SM; Alter DC; Shapiro MJ; Blair NP; Gieser JP
    Ophthalmology; 1999 Dec; 106(12):2286-90. PubMed ID: 10599658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin penetration into the eye after intravenous and topical administration.
    Fiscella RG; Shapiro MJ; Solomon MJ; Kurtz RM; Mui S; Labib S
    Retina; 1997; 17(6):535-9. PubMed ID: 9428017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration.
    George JM; Fiscella R; Blair M; Rodvold K; Ulanski L; Stokes J; Blair N; Pontiggia L
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):579-86. PubMed ID: 20977368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
    Bucci FA
    Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye.
    Puustjärvi T; Teräsvirta M; Nurmenniemi P; Lokkila J; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1633-7. PubMed ID: 16715252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes.
    Oztürk F; Kurt E; Inan UU; Kortunay MC; Ilker SS; Başci NE; Bozkurt A
    Int J Pharm; 2000 Aug; 204(1-2):91-5. PubMed ID: 11011990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops.
    Koch HR; Kulus SC; Roessler M; Ropo A; Geldsetzer K
    J Cataract Refract Surg; 2005 Jul; 31(7):1377-85. PubMed ID: 16105610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
    Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
    Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
    Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA
    Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ocular compression on intraocular penetration of systemic ofloxacin.
    Ugurbas SH; Can M; Koksal M; Dincel A; Bozkurt A; Bayar B
    Adv Ther; 2007; 24(2):394-401. PubMed ID: 17565931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans.
    Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M
    Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration.
    Healy DP; Holland EJ; Nordlund ML; Dunn S; Chow C; Lindstrom RL; Hardten D; Davis E
    Cornea; 2004 Apr; 23(3):255-63. PubMed ID: 15084858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous and aqueous penetration of orally administered gatifloxacin in humans.
    Hariprasad SM; Mieler WF; Holz ER
    Arch Ophthalmol; 2003 Mar; 121(3):345-50. PubMed ID: 12617704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration.
    Cekiç O; Batman C; Yasar U; Başci NE; Bozkurt A; Kayaalp SO
    Eye (Lond); 1999 Aug; 13 ( Pt 4)():555-8. PubMed ID: 10692930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K
    Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cataract surgery on ocular levels of topical moxifloxacin.
    Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
    Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.